GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Accumulated other comprehensive income (loss)

Cytophage Technologies (TSXV:CYTO) Accumulated other comprehensive income (loss) : C$4.21 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Cytophage Technologies's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2024 was C$4.21 Mil.

Cytophage Technologies's quarterly Accumulated other comprehensive income (loss) declined from Jun. 2024 (C$4.71 Mil) to Sep. 2024 (C$4.60 Mil) and declined from Sep. 2024 (C$4.60 Mil) to Dec. 2024 (C$4.21 Mil).

Cytophage Technologies's annual Accumulated other comprehensive income (loss) increased from Dec. 2022 (C$2.46 Mil) to Dec. 2023 (C$3.28 Mil) and increased from Dec. 2023 (C$3.28 Mil) to Dec. 2024 (C$4.21 Mil).

Cytophage Technologies Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Cytophage Technologies's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Accumulated other comprehensive income (loss) Chart

Cytophage Technologies Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Accumulated other comprehensive income (loss)
2.01 2.46 3.28 4.21

Cytophage Technologies Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 3.28 4.72 4.71 4.60 4.21

Cytophage Technologies Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Cytophage Technologies Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytophage Technologies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
TSXV:IBO XCNQ:BIOV TSXV:IOT XCNQ:GLOW TSXV:KNE XCNQ:BLAB TSXV:RKV TSX:RVX XCNQ:BETR TSX:APS VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
200A - 400 Fort Whyte Way, Oak Bluff, Oak Bluff, MB, CAN, R4G 0B1
Website
https://www.cytophage.com
Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics.

Cytophage Technologies Headlines

No Headlines